Clinical Study
The Effects of Helicobacter pylori Eradication on Proteinuria in Patients with Primary Glomerulonephritis
Table 2
Clinical and laboratory features of the patients before and after H. pylori eradication therapy.
| | MN group () | IgAN group () | FSGS group () | value |
| Male/female | 13/6 | 4/6 | 3/1 | NS | Age (years) | | | | NS | BMI (kg/m2) | | | | NS | Before therapy | | | | | Systolic BP (mmHg) | | | | NS | Diastolic BP (mmHg) | | | | NS | Hemoglobin (g/dL) | | | | NS | Glucose (mg/dL) | | | | NS | Creatinine (mg/dL) | | | | 0.011 | T. protein | | | | NS | Albumin (g/dL) | | | | NS | Proteinuria (Up/C) (g/day) | | | | NS | GFR (mL/min) | | | | NS | T. cholesterol (mg/dL) | | | | NS | Triglyceride (mg/dL) | | | | NS | hs-CRP | | | | NS | After therapy | | | | | Systolic BP (mmHg) | | | | NS | Diastolic BP (mmHg) | | | | NS | Hemoglobin (mg/dL) | | | | NS | Creatinine (mg/dL) | | | | 0.005 | T. protein (g/dL) | | | | NS | Albumin (g/dL) | | | | NS | Proteinuria (g/day) | | | | NS | GFR (mL/min) | | | | NS |
|
|
AMN: membranous nephropathy, IgAN: IgA nephropathy, FSGS: focal segmental glomerulosclerosis, NS: not significant, GFR: glomerular filtration rate.
|